Work

A within-trial cost-effectiveness analysis of panitumumab compared with bevacizumab in the first-line treatment of patients with wild-typeRASmetastatic colorectal cancer in the US

Year: 2018

Type: article

Source: Journal of Medical Economics

DOI: 10.1080/13696998.2018.1510409

Authors: Christopher N. Graham, Alexandra Christodoulopoulou, Hediyyih N. Knox, Lorenzo Sabatelli, Guy Hechmati, Tamer Garawin, John H. Strickler

Institutions: RTI Health Solutions, Amgen (United States), Amgen (Switzerland), Duke University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2886409983

FWCI: 1.895

Cites: 29

Cited by: 10

Related to: 10